Effect of Shock Wave Therapy on Myofascial Pain Syndrome in Adolescent Athletes

NCT ID: NCT06845475

Last Updated: 2025-02-25

Basic Information

• Recruitment Status: NOT_YET_RECRUITING
• Clinical Phase: NA
• Total Enrollment: 40 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2025-02-25
• Study Completion Date: 2025-05-05

Brief Summary

The purpose of the study is to determine the effect of extracorporeal shockwave therapy on pain, neck range of motion, and functional activity in adolescent athletes.

Detailed Description

Myofascial pain syndrome is a syndrome characterized by pain and accompanying muscle spasms, referred pain patterns, stiffness, and restricted range of motion caused by trigger points on constricted fibers of muscles and/or fasciae. Myofascial pain syndrome is the most common reason for back pain, shoulder pain, tension-type headaches, and regional pains such as facial pain.

Myofascial trigger points (MTrPs) are understood as the morphological correlate of the myofascial pain syndrome (MPS), an acute or chronic muscular pain condition affecting a single muscle or a group of muscles. Active MTrPs are spontaneously painful, while latent MTrPs are only painful upon pressure. MTrP stimulation can also cause referred pain and the characteristic local twitch response.

The main goal of MPS treatment is to break down the vicious circle of "spasm - pain - spasm" and release trigger points. Various physical therapy modalities such as trigger point injection, stretching-spray technique or ultrasound (US), heat packs and transcutaneous electrical nerve stimulation (TENS), and extracorporeal shock wave therapy (ESWT), are used for the treatment of MPS. These modalities inactivate the trigger point with their thermal and mechanical effects.

Due to the lack of research area of extracorporeal shock wave therapy on myofascial pain syndrome on upper trapezius in adolescents' athletes, so the purpose of the study is to know impact of the extracorporeal shock wave therapy on myofascial pain syndrome on upper trapezius in adolescents' athletes.

Conditions

Myofascial Pain Syndrome

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Designed physical therapy program

It will consist of 20 adolescents, who will receive a designed physical therapy program for the treatment of Myofascial pain syndrome.

Group Type: ACTIVE_COMPARATOR

Designed physical therapy program

Intervention Type: OTHER

Both groups will receive a designed physical therapy program, in the form of myofascial trigger points pressure release, stretching of the upper trapezius muscle, strengthening exercises, and infrared radiation for 4 weeks.

Designed physical therapy program + Extracorporeal shock wave therapy (ESWT)

It will consist of 20 adolescents, who will receive the same designed physical therapy program in addition to extracorporeal shock wave therapy (ESWT).

Group Type: EXPERIMENTAL

Designed physical therapy program

Intervention Type: OTHER

Both groups will receive a designed physical therapy program, in the form of myofascial trigger points pressure release, stretching of the upper trapezius muscle, strengthening exercises, and infrared radiation for 4 weeks.

Extracorporeal shock wave therapy (ESWT)

Intervention Type: OTHER

Adolescents of the experimental group will receive Extracorporeal shock wave therapy with the following parameters; low-level energy radial extracorporeal shock wave by (STORZ MEDICAL Master Pulse MP200), each subject received 3 sessions per week for 4 weeks with 700 impulse/session 400 impulse was applied to tight band and 300 impulses will be applied surrounding the tight band, with frequency \[10HZ\], resulting in positive energy flux density \[EFD\] 0.056mJ/mm.

Interventions

Designed physical therapy program

Both groups will receive a designed physical therapy program, in the form of myofascial trigger points pressure release, stretching of the upper trapezius muscle, strengthening exercises, and infrared radiation for 4 weeks.

Intervention Type: OTHER

Extracorporeal shock wave therapy (ESWT)

Adolescents of the experimental group will receive Extracorporeal shock wave therapy with the following parameters; low-level energy radial extracorporeal shock wave by (STORZ MEDICAL Master Pulse MP200), each subject received 3 sessions per week for 4 weeks with 700 impulse/session 400 impulse was applied to tight band and 300 impulses will be applied surrounding the tight band, with frequency \[10HZ\], resulting in positive energy flux density \[EFD\] 0.056mJ/mm.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Age ranges from 14 to 18 years.
• All adolescents have regional pain complaint.
• Tenderness in cervical trigger points in the midpoint of the upper border of the trapezius muscle, from grade 2 to grade 4 according to the tenderness grading scheme (Hubbard, 1993) (Appendix II).
• Palpation of a trigger point elicits a stereotypic zone of referred pain specific to that muscle.
• Identification of a palpable taut band, as well as a palpable, and exquisitely tender spot along the length of that taut band.
• All adolescents are allowed to practice their regular sports activities.

Exclusion Criteria

• Dermatological disorders.
• Having myofascial trigger points injection.
• Chronic pain in both sides of the body.
• History of findings of cervical injury whether orthopedic or soft tissue injury.
• Analgesic drugs or NSAIDs during the treatment period.

• Minimum Eligible Age: 14 Years
• Maximum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Cairo University

OTHER

Sponsor Role: lead

Responsible Party

Mohamed Hafez Mohamed

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Nanees Essam Mohamed Salem, PhD

Role: STUDY_CHAIR

Professor, Cairo university

Locations

Ismailia Medical Complex

Ismailia, , Egypt

Countries

Egypt

Central Contacts

Mohamed Hafez Mohamed, M.Sc

Role: CONTACT

drmohamedhafezpt@gmail.com

01201170770

Walaa Abd El Hakeem Abd El Nabi, PhD

Role: CONTACT

Facility Contacts

Mohamed Hafez Mohamed, M.Sc

Role: primary

drmohamedhafezpt@gmail.com

01201170770

Other Identifiers

P.T.REC/012/005356

Identifier Type: -

Identifier Source: org_study_id